Horizon 2020 Breaking News

Horizon 2020 Calls to be Extended

18 March 2020

IMPORTANT UPDATE-

The European Commission has an update to Horizon 2020 Calls. Due to the current situation with Covid-19, calls with deadlines between now and 15 April are extended. The exact dates and details will be published on each call and topic on their Funding and Tenders Portal. For now, the specific following calls are to be extended to 15 April:

–           SC1-BHC-37-2020 Towards the new generation of clinical trials – trials methodology research

–           SC1-BHC-06-2020 Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data

–           SC1-BHC-11-2020 Advancing the safety assessment of chemicals without the use of animal testing

–           SC1-BHC-17-2020 Global Alliance for Chronic Diseases (GACD) – Prevention and/or early diagnosis of cancer

–           SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions

–           SC1-BHC-20B-2020 Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases

–           SC1-BHC-33-2020 Addressing low vaccine uptake

–           SC1-BHC-34-2020 New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings

–           SC1-BHC-35-2020 Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases

–           SC1-BHC-36-2020 Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health

–           SC1-DTH-12-2020 Use of Real-World Data to advance research on the management of complex chronic conditions

–           SC1-HCC-10-2020 Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research

–           SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine

–           SC1-HCO-03-2020 Bridging the divide in health research and innovation – boosting return on investment

–           SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)

–           SC1-HCO-14-2020 ERA-NET: Sustained collaboration of national and regional programmes in cancer research

–           SC1-HCO-16-2020 ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system.

–           SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond

–           SC1-HCO-18-2020 Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices

–           SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies

–           SC1-HCO-20-2020 Coordination of clinical research activities of the European Reference Networks

 

2nd stage deadline moved to 15 April 2020:

–           SC1-BHC-08-2020 New interventions for Non-Communicable Diseases

–           SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient

–           SC1-BHC-29-2020 Innovative actions for improving urban health and wellbeing addressing environment, climate and socioeconomic factors

–           SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care

 

Click here for the link from the European Commission

 

 

Catalyze is here to help and provide you with informative support during this turbulent times. We are running as always with the ambition to get your innovations off the ground and running with adequate funding. For more information, check back on our blog, socials, or feel free to email us at info@catalyze-group.com

Newsletter

A must-have if you’re interested in getting your business to the next level